+100%-

No one suspected a 50 year old kidney drug called spironolactone might hold the key to a new generation of herpesvirus drugs.

University of Utah researchers hoped their new assay might uncover a new way to treat EBV infections – but they were shocked at what it turned up. How could a 50 year old kidney drug called Spironolactone have anything to do with EBV?

 
Four years later they knew how – and the possibility for a more effective drug to treat herpesvirus infections was borne.
 
The moral to this story – you never know where an answer may come from. It could even be sitting on an aisle in your pharmacy.
 
Find out more in a Simmaron Research Foundation sponsored blog:
 

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities. 

Thank you for signing up!

Pin It on Pinterest

Share This